Dr. Ralph Schiess (CSO) is a co-founder of Proteomedix AG. He graduated with a master of science from the University Zurich. After training at the Institute for Systems Biology in Seattle, US, Ralph Schiess earned his Ph.D. in science from the ETH Zurich where he developed the biomarker discovery technology and identified the prostate cancer biomarkers.